SIMABS

Agoralaan, Abis Abis /

3590 Diepenbeek

BE

SIMABS

Foundation date

22/08/2019

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

SIMABS is a start-up biotechnology venture that wants to develop a new bio-manufacturing platform to provide cost effective therapeutic monoclonal antibodies at small scale to biopharmaceutical companies.

Latest news

  • New software from UHasselt and ZEISS shows in sharp detail how biomolecules move in cells.

    21 hours ago

  • Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024

    22 hours ago

  • VIB-KU Leuven study reveals FUS protein’s role in ALS and FTD

    Friday June 14th 2024

Jobs by SIMABS